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Abstract
Objective—To assess microorganisms associated with vascular access-associated infections
(VAIs) in hemodialysis patients, with respect to possible origin from the mouth.
Study Design—A retrospective and comparative analysis of the microbes associated with VAI
in hemodialysis patients treated during a 10-year period was performed using the Human Oral
Microbiome Database (HOMD).
Results—Of 218 patient records identified, 65 patients collectively experienced 115 VAI
episodes. The most common microorganisms involved were Staphylococcus aureus (49.6% of
infections), Staphylococcus epidermidis (10.4%), Serratia marcescens (10.4%), Pseudomonas
aeruginosa (9.6%), and Enterococcus faecalis / fecum (8.7%). None of these was found in 1% or
more of HOMD clone libraries, indicating that they very rarely colonize the teeth or plaque.
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Conclusions—Most VAIs were associated with microorganisms more likely to originate from
other body sites than from the oral cavity. The risk of a VAI being caused by microorganisms
originating from the oral cavity is very small.

Introduction
Renal disease is becoming increasingly recognized as a global health care crisis with a
significant impact on the United States health care system. The United States has the second
highest prevalence of end-stage renal disease in the world.1 According to the U.S. Renal
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Data System, there were 598,311 persons with end-stage renal disease in the U.S. for the
period from the 4th quarter of 2009 to the 4th quarter of 2010.2 A large proportion of these
patients receive hemodialysis. Data from the Dialysis Surveillance Network indicate that
3.2% of hemodialysis patients have a dialysis access-related infection each month.3 Higher
susceptibility to infection in this population is caused by their immunocompromised status,
chronic systemic disease and illness, and repeated use of the vascular access site for
hemodialysis.3 These vascular access-related infections can lead to multiple morbidities
ranging from local infection to sepsis with multi-organ failure, and death. A 10 year review
of mortality rates in dialysis patients revealed that infection contributed to 24% of all
deaths.4

NIH-PA Author Manuscript

Due to the morbidity and mortality associated with vascular access-associated infections
(VAIs), the use of prophylactic antibiotics to prevent such infections is common prior to
general surgical procedures.5 This preventive practice has also been adopted with regards to
dental procedures. Some nephrologists or dentists prescribe prophylactic antibiotics to
prevent VAIs in hemodialysis patients undergoing dental treatment. However, a systematic
review by Lockhart et al. found that there is no scientific evidence linking oral
microorganisms to systemic infections in renal hemodialysis patients.6 While some dental
procedures can induce transient bacteremias,6, 7 there is no evidence that these bacteremias
cause VAIs. Further, guidelines from the American Heart Association indicate that antibiotic
prophylaxis is not routinely recommended for dental procedures in patients with
hemodialysis vascular access grafts.8 Both publications indicated that additional research is
needed on this issue. It is being increasingly recognized that such prophylactic use of
antibiotics may serve minimal benefit and can result in potential significant harm. The risks
of unnecessary antibiotic use include the development of resistant strains of bacteria;
financial costs to the patient and/or society; and risk of adverse reactions such as rash,
gastrointestinal upset, and possibly anaphylactic shock leading to death. Thus, the rationale
for antibiotic prophylaxis for various medically complex patient populations undergoing
invasive dental procedures is currently being challenged.6
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A survey of infectious disease specialists, regarding the need for antimicrobial prophylaxis
to prevent distant site infection, revealed differing opinions. Of 477 respondents questioned
specifically about prophylaxis for patients on hemodialysis with dialysis catheters or shunts,
less than 20% reported that they “always or usually” recommended such prophylaxis prior to
invasive dental procedures. Moreover, approximately 45% of the respondents indicated that
they “never” recommend prophylaxis for such patients.9 Importantly, 90% of these
infectious disease specialists indicated that additional research is needed to determine
indications for antibiotic prophylaxis before dental procedures in various medically complex
populations.9 There is thus a pressing need for additional data on whether oral
microorganisms can contribute to infections associated with vascular access in renal
hemodialysis patients. In this study, we sought to determine the potential role of oral
microorganisms in causing VAIs in hemodialysis patients, by identifying the
microorganisms associated with such infections and determining whether they are normal
inhabitants of the oral cavity.

Methods
This retrospective record review was conducted at the University of Connecticut Health
Center (UCHC). Approval for the study was received from the UCHC Institutional Review
Board and from Dialysis Clinic Inc. (DCI), which operates the UConn Dialysis Center in
Farmington, CT. All research procedures were conducted in compliance with the
Declaration of Helsinki. Electronic medical records were reviewed for all 218 patients
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undergoing renal hemodialysis at the UCHC Dialysis Clinic between January 1, 1999 and
February 27, 2009. Patients on peritoneal dialysis were not included.

NIH-PA Author Manuscript

A vascular access-associated infection (VAI) was defined as the occurrence of any of the
following types of dialysis events, as defined by the Centers for Disease Control and
Prevention.10
•

Local access infection: Pus, redness, or swelling of the vascular access site; and
access associated bacteremia was not present.

•

Access-associated bacteremia: Blood culture positive with source identified as the
vascular access site; or source was unknown (i.e. absence of any other documented
infection).10
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The following information was retrieved from the electronic medical records by a careful
review of progress notes and other records: demographic data including date of birth,
gender, and ethnicity/race; medical history information; mode of vascular access
(arteriovenous (AV) graft, AV fistula, catheter, or a combination); dates of VAIs; and
medical status at time of VAI. In addition, reports of microbial cultures (from blood and/or
vascular access sites) were reviewed to identify the specific microorganism(s) associated
with these infections. Microorganisms were identified by trained microbiology laboratory
personnel using standard culture techniques and biochemical analyses in the John Dempsey
Hospital clinical laboratory at the University of Connecticut Health Center.
To determine if microorganism(s) associated with VAIs could have originated from the oral
cavity, the Human Oral Microbiome Database11 was consulted. This is an NIH-supported
comprehensive online database listing all known bacteria found in the human oral cavity by
molecular cloning techniques. VAIs associated with bacteria were classified based on
whether or not the associated microorganism(s) were found in the HOMD. For VAIs
associated with yeast, this classification was based on literature documenting the presence of
the associated yeast in the oral cavity.12, 13
Data were recorded in an Excel database and analyzed using descriptive statistics to assess
the overall incidence of VAIs and nature of associated microorganisms. The proportions of
VAIs associated with microorganisms found in the HOMD, across the different vascular
access types, were compared using an Exact test because of small cell frequencies. A p value
less than 0.05 was considered statistically significant.
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Incidence of VAIs and Subject Characteristics
Of the 218 renal hemodialysis patients for whom medical records were reviewed, 65 patients
(29.8%) were found to have had at least one episode of a VAI. There were a total of 115
VAIs across these 65 patients. Therefore, a subsample of 65 patients and 115 VAIs was used
for further analyses. In the 65 patients who experienced VAIs, the mean age was 65.6 years;
66 percent were male (n = 43) and 34 percent were female (n = 22). Ethnicity/race for the 65
patients was as follows: 40 patients were White; 13 were Black; 9 were Hispanic; 1 was
Asian; and 2 were of unknown ethnicity/race. The most common co-morbidities in these
patients were diabetes mellitus (34 patients), hypertension (49 patients), and coronary artery
disease (17 patients), with many patients having multiple co-morbidities. Of the 115 VAIs,
50 (43.5%) occurred in patients with diabetes mellitus, 87 (75.7%) in patients with
hypertension, and 35 (30.4%) in patients with coronary artery disease. Of the 65 patients, 37
(56.9%) received hemodialysis through a catheter; 16 (24.6%) through an AV fistula; 3
(4.6%) through an AV graft; 8 (12.3%) received hemodialysis through two different
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vascular access types over the study period; and in 1 patient the involved access type(s) used
was not able to be determined. Of the 8 patients who had 2 different access types over the
study period, 7 patients received hemodialysis through a catheter and an AV fistula, and 1
patient received hemodialysis through a catheter and an AV graft.
Characteristics of VAIs
Of the 115 episodes of VAI, 60 (52.2%) met the CDC definition of local access infection
and 55 (47.8%) met the CDC definition of access-associated bacteremia. Of the 115
episodes of VAI, 63 (56%) episodes involved patients with a catheter; 22 (19%) episodes
involved patients with an AV fistula; 20 (17%) episodes involved patients with both a
catheter and a fistula; 5 (4%) episodes involved patients with a graft; and 4 (3%) episodes
involved patients with both a catheter and a graft. The access type for one VAI episode was
not able to be determined based on available records.
Microorganisms Associated with VAIs
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Twenty-eight different microorganisms were identified in association with the 115 episodes
of VAI across 65 patients. Of these 28 microorganisms, 25 (89.3%) were bacteria identified
at the species level; 2 (6.9%) were yeast identified at the species level; and 1 (3.4%) was a
bacterium identified at the genus level. Staphylococcus aureus (including methicillinresistant Staphylococcus aureus (MRSA)) was the most common microorganism associated
with VAIs, involved in 57 of the 115 (49.6%) episodes. Other prominent bacteria included
Serratia marcescens (10.4%), Staphylococcus epidermidis (10.4%), Pseudomonas
aeruginosa (9.6%), and Enterococcus faecalis / fecum (8.7%) (Tables 1 and 2). Of the 115
VAIs, 22 were associated with more than one microorganism (polymicrobial infections).
VAIs Associated with Infrequent Colonizers of the Teeth and Plaque
Of the 25 VAI-associated bacteria identified at the species level, 12 were found in the
HOMD. All of these microorganisms were identified in very low clone numbers in the
HOMD, ranging from 3 to 171, of a total of 34,879 total clones tested for the HOMD
project. Ninety-six VAIs were associated with bacteria found in the HOMD and 4 VAIs
were associated with yeast (Candida albicans or Candida parapsilosis) that have been
isolated from the oral cavity.12,13Staphylococcus aureus (including MRSA) (involved in 57
VAIs) and Staphylococcus epidermidis (12 VAIs) were the most common of such
microorganisms associated with VAIs. However, their prevalence in the HOMD clone
libraries is extremely low (less than 0.05%). Since most samples for the HOMD project
were derived from teeth and subgingival plaque, low prevalence in the HOMD clone
libraries indicates that these microorganisms infrequently colonize the teeth and plaque.

NIH-PA Author Manuscript

Association of Infrequent Colonizers of Teeth/Plaque with VAIs, by Vascular Access Type
Of the 63 VAIs associated with a catheter alone, 54 (86%) were associated with at least one
microorganism that can infrequently colonize the teeth and plaque, based on presence in the
HOMD in low clone numbers. For fistulas alone, this number was 20 of 22 (91%) VAIs and
for grafts alone, 5 of 5 (100%) VAIs. Of the patients who had 2 different access types over
the study period, 16 of the 20 VAIs (80%) in patients with both a catheter and a fistula were
associated with infrequent colonizers of teeth and plaque. In patients with both a catheter
and a graft, all 4 VAIs were associated with infrequent colonizers of teeth and plaque. There
was no significant difference among the different access types in the proportion of VAIs
with involvement of infrequent colonizers of teeth and plaque (p = 0.654).
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Lack of Involvement of the Most Common Colonizers of Teeth and Plaque in VAIs
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To assess the involvement of the most common colonizers of teeth and plaque with VAIs,
we examined the most common microorganisms in the HOMD, ordered according to the
number of clones in which each microorganism was identified. A total of 16 specific
microorganisms (Table 3) were found in 1% or more of the 34,879 total clones tested for the
HOMD project. Thus, these were the microorganisms most commonly isolated from the oral
cavity in the HOMD project. A comparison of these 16 bacteria with those found to be
associated with VAIs (Table 1), found that none of these 16 bacteria were associated with
VAIs.

Discussion
Infections associated with vascular access are a significant source of morbidity in
hemodialysis patients. The results of this retrospective chart review indicated that almost
one-third of the hemodialysis patients reviewed experienced at least one VAI, with many
experiencing multiple infections.
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In order to examine the potential contribution of the oral microflora to VAIs, we examined
the microorganisms associated with the VAIs, with respect to whether they are normal
inhabitants of the oral cavity. A large proportion of the VAIs were found to be associated
with at least one microorganism that is present in the HOMD for bacteria. However, these
microorganisms were found in the HOMD in very low clone numbers. The extremely
sensitive molecular techniques, including amplification, used for the HOMD can result in
the inclusion of microorganisms present in very small numbers, as well as at very low
prevalence. It should be noted that prevalence in the HOMD clone libraries does not
numerically equal prevalence in the general population. This is because the HOMD
combined samples from several different studies, health states, and oral sites, in unequal
proportions, and using different primer pairs.14 All these variables can impact on the
prevalence of a given microorganism in the HOMD clone libraries. However, in general,
those microorganisms found in the HOMD at highest clone numbers are highly likely to be
the most prevalent in the oral microbial population and vice versa. Further, most of the
HOMD samples were derived from subgingival plaque and teeth. Since these sites are the
major contributors to any bacteremia secondary to the most common invasive dental
procedures (such as extractions), the HOMD actually better represents the microbiology of
these sites than a sampling of all sites in the oral cavity. Thus, it is far more likely that these
VAI-associated microorganisms originated from another body site. For example, the
bacteria associated with the largest number of VAIs were Staphylococcus aureus and
Staphylococcus epidermidis, which are much more likely to originate from the skin than
from the mouth.15-17 This is also supported by the very low prevalence of these
microorganisms in the HOMD clone libraries.
To specifically assess the role of the most common colonizers of teeth and plaque in VAIs,
we compared the bacteria most commonly found in the HOMD to those associated with
VAIs in our study sample. This comparison showed that none of the most common
colonizers of teeth and plaque was found to be associated with a VAI. Lockhart18 identified
microorganisms from blood cultures taken at 1 minute (53 microorganisms) and 3 minutes
(65 microorganisms) after the initiation of a dental extraction. Thus, these microorganisms
constituted a bacteremia induced by an invasive dental procedure. Only 1 specific
microorganism thus identified (Streptococcus salivarius) was found to be associated with a
single VAI in our study. Collectively, these data indicate that is exceedingly unlikely to find
a VAI-associated microorganism colonizing the teeth and plaque.
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Shariff et al.19 examined microbial blood culture data involving a total of 72 VAIs in a
group of 51 hemodialysis patients (32 patients via retrospective chart review and 19 patients
prospectively). Most of the infections were found to be caused by Staphylococci and
Enterococci, which is consistent with our findings. These were classified as “unlikely or
rarely oral flora”, based on the available literature. Therefore the authors concluded that oral
microorganisms rarely, if ever, cause vascular access infections in hemodialysis patients. In
the current study, we used a different method of classifying microorganisms, based on
presence or absence in the Human Oral Microbiome Database. This database includes all
bacteria that have been identified in the oral cavity by molecular cloning techniques. Despite
the different methods of classifying microorganisms, results from both studies
predominantly implicated microorganisms that are more likely to originate from sites other
than the oral cavity.
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A limitation of our study was that the medical records did not provide documentation on any
dental procedures for the patients reviewed, and we did not have access to their dental
records. This precluded investigation into any temporal relationships between invasive
dental procedures and subsequent VAIs. Due to the retrospective nature of the study, we
could not obtain oral cultures or information on the oral health status of the subjects. Thus,
no evaluation of the relationship between oral status and VAIs was possible. Another
limitation was that standard culture methods were used by the clinical laboratory for
identification of microorganisms. Bahrani-Mougeot et al. demonstrated that DNA
sequencing results in more accurate identification of bacteria than culture-based
techniques.20 However, the standard culture-based techniques are well-accepted and used in
most hospitals for speciation and to base clinical treatment decisions on.
In conclusion, this study suggests that the true risk of a VAI caused by microorganisms
originating from the oral cavity is very small. These findings support the AHA
recommendation that antibiotic prophylaxis is not routinely needed for dental procedures in
hemodialysis patients.
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Statement of Clinical Relevance

NIH-PA Author Manuscript

These findings suggest that oral microorganisms are rarely involved in causing infections
associated with vascular access in hemodialysis patients. These data support the
American Heart Association recommendation that antibiotic prophylaxis is not routinely
needed for dental procedures in such patients.
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Table 1
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Vascular Access Infection (VAI) - associated microorganisms that are found in the Human Oral Microbiome
Database (HOMD)
Number of VAIs associated with each
microorganism by type of access
device
Total Number of VAIs Associated
with Each Microorganism

Catheter

Graft

Fistula

Access
Device
Unknown

Bacteria identified at the species level
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Acinetobacter
baumannii

2

1

0

0

0

Burkholderia
cepacia

1

1

0

0

0

Enterococcus
faecalis / fecum

10

6

1

3

0

Escherichia coli

5

4

0

1

0

Klebsiella
pneumoniae

6

3

1

2

0

Pseudomonas
aeruginosa

11

9

2

0

0

Staphylococcus
aureus

31

22

3

5

1

Methicillinresistant
Staphylococcus
aureus

26

13

1

12

0

Staphylococcus
epidermidis

12

8

0

4

0

Staphylococcus
warneri

1

0

0

0

0

Stenotrophomonas
maltophilia

2

0

0

2

0

Streptococcus
agalactiae

1

0

0

1

0

Streptococcus
salivarius

1

0

0

1

0

Candida albicans

2

2

0

0

0

Candida
parapsilosis

2

2

0

0

0

1

1

0

0

0

Yeasts identified at the species level
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Bacteria identified at the genus level
Streptococcus
alpha haemolytic
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Table 2
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Vascular Access Infection (VAI) - associated microorganisms that are NOT found in the Human Oral
Microbiome Database (HOMD)

Name of Microorganism

Total Number
of VAIs
Associated with
Each
Microorganism

Number of VAIs associated with each
microorganism by type of access device
Catheter

Graft

Fistula

Unknown
Access
Device

Bacteria identified at the species level
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Acinetobacter haemolyticus

1

1

0

0

0

Bacteroides fragilis

1

1

0

0

0

Enterobacter asburiae

1

1

0

0

0

Enterobacter aerogenes

2

2

0

0

0

Enterobacter cloacae

3

3

0

0

0

Escherichia vulneris

1

1

0

0

0

Morganella morganii

1

1

0

0

0

Pasteurella multocida

1

1

0

0

0

Providencia stuartii

2

2

0

0

0

Serratia marcescens

12

10

0

2

0

Staphylococcus auricularis

1

1

0

0

0

Staphylococcus hominis subsp. hominis

3

0

0

3

0

Staphylococcus saccharolyticus

1

1

0

0

0
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Table 3
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Most common specific microorganisms present in the HOMD (defined as those species found in 1% or more
of clones tested for the HOMD project).
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Rank in the
HOMD

Microorganism

1

Veillonella parvula

2

Streptococcus mitis

3

Streptococcus mutans

4

Streptococcus sanguinis

5

Veillonella dispar

6

Streptococcus anginosus

7

Gemella morbillorum

8

Gemella haemolysans

9

Granulicatella adiacens

10

Streptococcus gordonii

11

Fusobacterium nucleatum subsp. vincentii

12

Dialister invisus

13

Streptococcus mitis bv. 2

14

Streptococcus parasanguinis II

15

Campylobacter gracilis

16

Selenomonas noxia
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